332 related articles for article (PubMed ID: 3007614)
1. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
Winfield JB; Shaw M; Minota S
J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
[TBL] [Abstract][Full Text] [Related]
2. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
Minota S; Winfield JB
J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
[TBL] [Abstract][Full Text] [Related]
3. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
4. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
Minota S; Winfield JB
J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
[TBL] [Abstract][Full Text] [Related]
5. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
Litvin DA; Cohen PL; Winfield JB
J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
[TBL] [Abstract][Full Text] [Related]
6. Surface antigen specificity of cold-reactive IgM antilymphocyte antibodies in systemic lupus erythematosus.
Yamada A; Shaw M; Winfield JB
Arthritis Rheum; 1985 Jan; 28(1):44-51. PubMed ID: 2578282
[TBL] [Abstract][Full Text] [Related]
7. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines.
Sano H; Kumagai S; Namiuchi S; Uchiyama T; Yodoi J; Maeda M; Takatsuki K; Suginoshita T; Imura H
Clin Exp Immunol; 1986 Jan; 63(1):8-16. PubMed ID: 3006953
[TBL] [Abstract][Full Text] [Related]
9. Anti-lymphocyte antibodies in systemic lupus erythematosus and in Hodgkin's disease: a comparison by immunofluorescence.
Del Giacco GS; Leone AL; Locci F; Manconi PE; Tognella S; Mantovani G; Grifoni V
Biomedicine; 1976 May; 25(3):79-80. PubMed ID: 779861
[TBL] [Abstract][Full Text] [Related]
10. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.
Glinski W; Gershwin ME; Steinberg AD
J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.
Yamada A; Winfield JB
J Clin Invest; 1984 Dec; 74(6):1948-60. PubMed ID: 6210306
[TBL] [Abstract][Full Text] [Related]
12. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
13. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
[TBL] [Abstract][Full Text] [Related]
14. Studies on antilymphocyte antibodies in patients with rheumatoid arthritis and systemic lupus erythematosus.
Winchester RJ; Winfield JB; Fu SM; Wernet P; Kunkel HG
Rheumatology; 1975; 6():209-14. PubMed ID: 1081726
[TBL] [Abstract][Full Text] [Related]
15. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
Dieudé M; Senécal JL; Raymond Y
Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
[TBL] [Abstract][Full Text] [Related]
16. Modulation of T3 antigen in systemic lupus erythematosus (SLE).
Surányi P; Czirják L; Szegedi G; Damjanovich S
Acta Med Hung; 1987; 44(4):311-9. PubMed ID: 2965337
[TBL] [Abstract][Full Text] [Related]
17. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Tac antigen on activated human T cells by anti-Tac monoclonal antibody.
Tsudo M; Uchiyama T; Takatsuki K; Uchino H; Yodoi J
J Immunol; 1982 Aug; 129(2):592-5. PubMed ID: 6979578
[TBL] [Abstract][Full Text] [Related]
19. Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.
Bahr GM; Rook GA; Moreno E; Lydyard PM; Modabber FZ; Stanford JL
Immunology; 1980 Dec; 41(4):865-73. PubMed ID: 6161879
[TBL] [Abstract][Full Text] [Related]
20. Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen.
Schroff RW; Klein RA; Farrell MM; Stevenson HC
J Immunol; 1984 Oct; 133(4):2270-7. PubMed ID: 6236264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
